Lindsey Lee Lair, MD, FAAN is the VP of Clinical Development at Biohaven Pharmaceuticals with expertise in clinical development and scientific strategy to ensure successful product development and commercialization globally. Global experience in all life cycle phases and has delivered launch innovation and excellence. Experience in market access activities, scientific leader engagement, matrix management, clinical research support, strategic alliance management, medical information and training, and global promotion review including high profile campaigns and social media. Excels at distilling complex data into actionable insights to add value and drive results on target.
Proven leadership expertise beyond the therapeutic area. She is a leader in neurology, and is a Fellow of the American Academy of Neurology (FAAN). Selected for the Merck Women’s Leadership Program and the American Academy of Neurology (AAN) advocacy leadership forum. High achieving Merck Political Action Committee (PAC) ambassador and AAN PAC founding member. Conducted healthcare policy discussions with congress members on Capitol Hill. Teaches ethics as a Clinical Assistant Professor at New York Medical College, and helps shape healthcare policy and practice as a board member of the NY State Neurological Society.